The medicines for children agenda in the UK

British Journal of Clinical Pharmacology

Volumn 61, Issue 6, 2006, Pages 716-719

  Stephenson, Terence ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

British National Formulary for Children; Drug therapy; Medicines for Children; Paediatrics

Indexed keywords

CHLORAMPHENICOL; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

CHILD; CHILDHOOD DISEASE; CONSENSUS; DEPRESSION; DRUG FORMULARY; DRUG INDUSTRY; DRUG USE; EVIDENCE BASED MEDICINE; GRAY BABY SYNDROME; HUMAN; LICENSING; OFF LABEL DRUG USE; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SUICIDAL BEHAVIOR; UNITED KINGDOM;

BIOMEDICAL RESEARCH; CHILD; GREAT BRITAIN; HUMANS; PEDIATRICS; PHARMACEUTICAL PREPARATIONS; PRACTICE GUIDELINES; PRACTICE GUIDELINES AS TOPIC;

EID: 33646942668     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2006.02676.x     Document Type: Review

References (22)

1. Stephenson T. Implications of the Crown Report and nurse prescribing. Arch Dis Child 2000 83: 199 202.
2. Turner S, Gill A, Nunn T, Hewitt B, Choonara I. Use of 'off label' and unlicensed drugs in paediatric intensive care unit. Lancet 1996 347 9000 549 50.
3. The Specific Health Needs of Children and Young People. Second Report. House of Commons Health Committee 1997 1.
4. Turner S, Longworth A, Nunn AJ, Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ 1998 316 7128 343 5.
5. Conroy S, McIntyre J, Choonara I. Unlicensed and off label drug use in neonates. Arch Dis Child Fetal Neonatal Ed 1999 80: F142 5.
6. McIntyre J, Conroy S, Avery A, Corns H, Choonara I. Unlicensed and off label drug use in general practice. Arch Dis Child 2000 83I: 498 501.
7. Chalumeau M, Tréluyer JM, Salanave B, Assathiany R, Chéron G, Crocheton N, Rougeron C, Mares M, Bréart G, Pons G. Off label and unlicensed drug use among French office based paediatricians. Arch Dis Child 2000 83: 502 5.
8. Stephenson T. How children's responses to drugs differ from adults. Br J Clin Pharmacol 2005 59: 670 3.
9. European Agency for the Evaluation of Medicinal Products/Committee for Proprietary Medicinal Products (CPMP). Notes for Guidance on Clinical Investigation of Medicinal Products in Children (EWP/462/95). London: Medicines Control Agency 1997.
10. Rylance G, Harvey D, Aranda J. Neonatal Clinical Pharmacology and Therapeutics. Oxford: Butterworth Heineman 1991.
11. Turner S, Nunn AJ, Fielding K, Choonara I. Adverse reactions to unlicensed and off-label drugs on paediatric wards. Acta Paediatr 1999 88: 965 8.
12. Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet 2004 363 9418 1341 5.
13. Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL. Efficacy and safety of antidepressants for children and adolescents. BMJ 2004 328 7444 879 83.
14. Royal College of Paediatrics and Child Health. Report of the Practice Quality Committee. Standards for Development of Clinical Guidelines in Paediatrics and Child Health: Role of the Royal College of Paediatrics and Child Health. London: RCPCH 1998.
15. Hull D. Birth of a formulary. Arch Dis Child 1999 81: 197 201.
16. Medicines for Children. London: RCPCH Publications Limited on behalf of the Royal College of Paediatrics and Child Health and the Neonatal and Paediatric Pharmacists Group 1999.
17. Bolam v Friern Hospital Management Committee [1957] 2 All ER 118, 1957 1 WLR, 582.
18. Bolitho v City and Hackney Health Authority [ 1998 ] Lloyd's Rep Med 26.
19. Royal College of Paediatrics and Child Health. Safer and Better Medicines for Children. London: RCPCH 2004.
20. Stephenson T. Medicines for children - past, present and future. In: Paediatric Clinical Research Manual, Helms P, Stonier P. Haslemere, Surrey: Euromed Communications Ltd 2005: 1 17.
21. Bowker R, Stephenson T. New medicines for children: who is protecting the rights of the child?. In: Ethical, Legal and Social Aspects of Child Healthcare, Cartlidge PT. Oxford: Elsevier Ltd 2006.
22. Aronson JK. Rare diseases and orphan drugs. Br J Clin Pharamcol 2006 61: 243 5.